PARIS, July 30, 2008 /PRNewswire-FirstCall via COMTEX/ -- 2008 HALF-YEAR RESULTS EUR'000,000 2008 2007 Revenues 92. After factoring in the financial result, the tax expense and the share in net income from equity affiliates, respectively representing - 2. The current outlook for activity over the second half of 2008 shows an improvement for the Pharmaceutical Synthesis division, while a downturn is forecast for the Fine Chemicals division within a more difficult environment. Historical and current end-of-day data provided by Interactive Data Pricing and Reference Data . read more